Book
Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou.
Record details
- ISBN: 152473165X
- ISBN: 9781524731656 (hardback)
- ISBN: 9781524731656 : HRD
- ISBN: 152473165X : HRD
- ISBN: 9781524731656 (hardcover)
- ISBN: 152473165X (hardcover)
- Physical Description: x, 339 pages ; 25 cm
- Edition: First edition.
- Publisher: New York : Alfred A. Knopf, 2018.
- Copyright: ©2018
Content descriptions
| Bibliography, etc. Note: | Includes bibliographical references and index. |
| Formatted Contents Note: | A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue. |
| Summary, etc.: | In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley. |
Search for related items by subject
Available copies
- 42 of 43 copies available at Bibliomation.
- 1 of 1 copy available at Rockville Public Library. (Show preferred library)
Holds
- 0 current holds with 43 total copies.
Other Formats and Editions
Show Only Available Copies
| Location | Call Number / Copy Notes | Barcode | Shelving Location | Status | Due Date |
|---|---|---|---|---|---|
| Rockville Public Library | 338.7681 CAR (Text) | 34035142488416 | Adult Nonfiction | Available | - |
| Ansonia Public Library | 338.7 CAR (Text) | 34045138752360 | Adult Nonfiction | Available | - |
| Beekley Community Library - New Hartford | 338.7 CARREYROU, J. (Text) | 32544072514168 | Adult Nonfiction | Checked out | 05/19/2024 |
| Bethel Public Library | 338.7 CAR (Text) | 34030142370102 | Adult Nonfiction | Available | - |
| Brookfield Library | 338.7681/CARREYROU (Text) | 34029145292917 | Adult Nonfiction | Available | - |
| Burnham Library - Bridgewater | 338.7 CARREYROU (Text) | 36937000621939 | Adult Nonfiction | Available | - |
| C.H. Booth Library - Newtown | 338.7 CAR (Text) | 34014142310417 | Adult Nonfiction | Available | - |
| Canterbury Public Library | 338.76 CARREYROU (Text) | 33190000430413 | Adult Nonfiction | Available | - |
| David M. Hunt Library - Falls Village | 338.7 Car (Text) | 33180141806480 | Adult Nonfiction | Available | - |
| Derby Neck Library | 338.76 CAR (Text) | 34046145336650 | Adult Nonfiction | Available | - |
Electronic resources
| LDR | 03343cam a2200505Ii 4500 | ||
|---|---|---|---|
| 001 | on1029779381 | ||
| 003 | OCoLC | ||
| 005 | 20180703103011.0 | ||
| 008 | 180316t20182018nyu b 001 0 eng | ||
| 010 | . | ‡a 2018000263 | |
| 020 | . | ‡a152473165X | |
| 020 | . | ‡a9781524731656 (hardback) | |
| 020 | . | ‡a9781524731656 : HRD ‡c27.95 | |
| 020 | . | ‡a152473165X : HRD ‡c27.95 | |
| 040 | . | ‡aDLC ‡beng ‡erda ‡cDLC ‡dOCLCO ‡dSSH ‡dOCLCF ‡dJSE ‡dFEM ‡dQQ3 ‡dJTH ‡dYDX ‡dCZA ‡dOCLCO ‡dJQM ‡dIMD ‡dTXM ‡dNDS ‡dTXDRI ‡dRCJ ‡dCOO ‡dJRA ‡dTXWHS ‡dSMU ‡dORK ‡dTXMAL | |
| 066 | . | ‡cZsym | |
| 019 | . | ‡a1019646846 | |
| 020 | . | ‡a9781524731656 (hardcover) | |
| 020 | . | ‡a152473165X (hardcover) | |
| 037 | . | ‡bRandom House Inc, Attn Order Entry 400 Hahn rd, Westminster, MD, USA, 21157 ‡nSAN 201-3975 | |
| 042 | . | ‡apcc | |
| 043 | . | ‡an-us--- | |
| 050 | 0 | 0. | ‡aHD9995.H423 ‡bU627 2018 |
| 082 | 0 | 0. | ‡a338.7/681761 ‡223 |
| 084 | . | ‡aBUS025000 ‡aBUS027000 ‡aTEC059000 ‡2bisacsh | |
| 049 | . | ‡aBIBA | |
| 100 | 1 | . | ‡aCarreyrou, John, ‡eauthor. |
| 245 | 1 | 0. | ‡aBad blood : ‡bsecrets and lies in a Silicon Valley startup / ‡cJohn Carreyrou. |
| 250 | . | ‡aFirst edition. | |
| 264 | 1. | ‡aNew York : ‡bAlfred A. Knopf, ‡c2018. | |
| 264 | 4. | ‡c©2018 | |
| 300 | . | ‡ax, 339 pages ; ‡c25 cm | |
| 336 | . | ‡atext ‡btxt ‡2rdacontent | |
| 337 | . | ‡aunmediated ‡bn ‡2rdamedia | |
| 338 | . | ‡avolume ‡bnc ‡2rdacarrier | |
| 504 | . | ‡aIncludes bibliographical references and index. | |
| 505 | 0 | . | ‡aA purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue. |
| 520 | . | ‡aIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley. | |
| 600 | 1 | 0. | ‡aHolmes, Elizabeth Anne, ‡d1984- |
| 610 | 2 | 0. | ‡aTheranos (Firm) ‡xHistory. |
| 650 | 0. | ‡aHematologic equipment industry ‡zUnited States. | |
| 650 | 0. | ‡aNew business enterprises ‡xCorrupt practices ‡zUnited States ‡vCase studies. | |
| 650 | 0. | ‡aSecurities fraud ‡zUnited States ‡vCase studies. | |
| 880 | 4. | ‡6264-00 ‡c | |
| 938 | . | ‡aYBP Library Services ‡bYANK ‡n15083235 | |
| 938 | . | ‡aBrodart ‡bBROD ‡n121475832 | |
| 994 | . | ‡aC0 ‡bBIB | |
| 905 | . | ‡uesattler | |
| 901 | . | ‡aon1029779381 ‡bDLC ‡c4084331 ‡tbiblio ‡sOCLC | |
